Cetuximab, capecitabine, and oxaliplatin (Cet-CapOx) with concurrent radiotherapy (RT) in advanced rectal cancer (RC): Results of a phase I/II trial No significant financial relationships to disclose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback